Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.

AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., Ltd. and GSK have renewed a five-year global manufacturing partnership.

Spring Modulith supports the development of functionally modularized Spring Boot applications. With Spring Modulith, it is possible to divide Spring Boot applications into functional modules with ...

Feb 23 (Reuters) - AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient ...

AbbVie’s $100 billion splurge on domestic manufacturing and R&D is continuing to come into focus, this time with a $380 million investment in two new active pharmaceutical ingredient manufactur | The ...

AbbVie is investing $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its headquarters campus in North Chicago. Construction is set to begin in spring 2026, ...

AbbVie is investing $380 million to build two new active pharmaceutical ingredient (API) manufacturing facilities at its ...

ByteDance's viral video generation model Seedance 2.0 was closely integrated with the Spring Festival gala's programming on Monday night China's "big tech" giants - including Alibaba Group Holding, ...

AbbVie invests $380m in North Chicago for API manufacturing, creating 300 jobs, boosting US R&D, and expanding domestic ...

New API enables enterprises, agencies, and SaaS platforms to integrate AI search visibility directly into internal ...

［株式会社バンダイナムコエクスペリエンス］株式会社バンダイナムコエクスペリエンスは「あそびパークPLUS」全12店舗にて、2026年2月27日(金)～5月31日(日)の期間、春を楽しむイベント『HAPPY SPRING』を開催します。「あそびパークPLUS」は明るく広々とした解放感のある芝生が広がる空間の中で、子どもたちがのびのびと夢中になれる遊びがたくさん詰まった親子のためのあそび場です。天候に ...